101. Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation
- Author
-
Abhinav Dhall, Nicholas P. Marotta, Franziska Meier, Matthew R. Pratt, Champak Chatterjee, Ralf Langen, Jobin Varkey, and Tharindumala Abeywardana
- Subjects
Models, Molecular ,Protein Conformation ,Molecular Sequence Data ,Ubiquitin-conjugating enzyme ,Protein aggregation ,Biochemistry ,Catalysis ,Article ,chemistry.chemical_compound ,Colloid and Surface Chemistry ,Protein structure ,Ubiquitin ,medicine ,Humans ,Amino Acid Sequence ,Disulfides ,Alpha-synuclein ,biology ,Neurodegeneration ,Ubiquitination ,Parkinson Disease ,General Chemistry ,medicine.disease ,Semisynthesis ,Ubiquitin ligase ,nervous system diseases ,chemistry ,nervous system ,biology.protein ,alpha-Synuclein - Abstract
The process of neurodegeneration in Parkinson’s Disease is intimately associated with the aggregation of the protein α-synuclein into toxic oligomers and fibrils. Interestingly, many of these protein aggregates are found to be post-translationally modified by ubiquitin at several different lysine residues. However, the inability to generate homogeneously ubiquitin modified α-synuclein at each site has prevented the understanding of the specific biochemical consequences. We have used protein semisynthesis to generate nine site-specifically ubiquitin modified α-synuclein derivatives and have demonstrated that different ubiquitination sites have differential effects on α-synuclein aggregation.
- Published
- 2012